Annual banned-substance review: the Prohibited List 2008-analytical approaches in human sports drug testing.
The list of prohibited substances and methods of doping issued by the World Anti-Doping Agency is updated and modified annually based on most recent developments and scientific data. Compounds and methods are maintained, added, or removed from the list, or they are placed in so-called monitoring programmes that have been established to obtain reliable data on the prevalence of particular substances and methods in- and/or out-of-competition. Consequently, doping control laboratories continuously update, modify and optimize existing screening and confirmation assays to ensure utmost comprehensiveness in detecting the prohibited and monitored substances as well as chemically and pharmacologically related analogs. The annual banned-substance review for human sports drug testing critically summarizes recent innovations in analytical approaches supporting the detection of established and newly outlawed substances and methods of doping. Literature from January 2007 through September 2008 as indexed in Medline and Web of Science was screened and articles on detection methods for substances and methods of doping in humans were compiled according to the 2008 Prohibited List of the World Anti-Doping Agency. Few new approaches were presented for individual doping agents and the majority of reports demonstrated new options for increasing the comprehensiveness of existing doping control assays. In addition, new techniques in separation and/or ionization of analytes complementary to commonly used procedures were described, which, so far, did not meet all requirements of sports drug testing.
Thevis
Mario
M
Center for Preventive Doping Research-Institute of Biochemistry, German Sport University Cologne, 50933 Cologne, Germany. thevis@dshs-koeln.de
Kuuranne
Tiia
T
Geyer
Hans
H
Schänzer
Wilhelm
W
D000318:Adrenergic beta-Agonists / Q000032:analysis; D045930:Anabolic Agents / Q000032:analysis; D004300:Doping in Sports; D006728:Hormones / Q000032:analysis; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis; D009294:Narcotics / Q000032:analysis; D015813:Substance Abuse Detection / Q000379:methods*
D000318:Adrenergic beta-Agonists; D045930:Anabolic Agents; D006728:Hormones; D036341:Intercellular Signaling Peptides and Proteins; D009294:Narcotics